Analyst price target range
Neuropace Price Target: $20.22 Average
Direct answer
Neuropace's average price target is $20.22.
The verified analyst range runs from $18.00 to $22.00.
The low target implies +22%, the high target implies +49.1%, and the range spans 27.1% of the current price.
Forecast evidence checked September 8, 2026.
Get free Neuropace email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $14.76
- Average price target
- $20.22
- High price target
- $22.00
- Low price target
- $18.00
- Low target gap
- +22%
- Target upside
- +37%
- High target gap
- +49.1%
- Target range width
- 27.1%
- Consensus rating
- none
- Analysts
- 9
- Evidence date
- September 8, 2026
- Valid through
- September 15, 2026
Explore related company data
Read the frequently asked questions.
What is Neuropace's average price target?
Neuropace's verified average price target is $20.22. The target range is $18.00 to $22.00.
How far are Neuropace's low and high targets from the recorded price?
The low target implies +22%, while the high target implies +49.1%.
How many analysts are included in Neuropace's consensus?
The verified consensus includes 9 analysts.
How is Neuropace's target upside or downside calculated?
The average target of $20.22 is divided by the recorded price of $14.76, then one is subtracted to produce +37%. This does not guarantee a future return.
When was Neuropace's analyst forecast verified?
The data was verified on 2026-09-08. The dataset is valid through 2026-09-15.